Searchable abstracts of presentations at key conferences in endocrinology

ea0029p96 | Adrenal cortex | ICEECE2012

Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?

Mysliwiec J. , Zukowski L. , Gorska M.

Introduction: Assessment of the RAAS has been recently granted a much greater role in the evaluation of patients with arterial hypertension (AH). There is no single test efficient in selection of patients for second-step etiological investigation.Methods: 198 consecutive patients- 119 women (60%) and 79 men (40%)- hospitalized in years 2009-2011 at the Clinical Department of Endocrinology UMB as to diagnose PA. In each patient PRA and PAC (basic and afte...

ea0049ep31 | Adrenal cortex (to include Cushing's) | ECE2017

The role of CYP11B2 polymorphism in the pathogenesis of hypertension in patients with adrenal incidentaloma

Zukowski Lukasz , Wawrusiewicz-Kurylonek Natalia , Mysliwiec Janusz , Gorska Maria

Background: Significant prevalence of hypertension in the world’s population and its consequences tend to an intensive search for pathogenesis and etiology of this disease. Epidemic of hypertension is accompanied by an epidemic of adrenal incidentaloma and grows in direct proportion to patients age. Polymorphism of aldosterone synthase (CYP11B2) in -344th region of promoter seems to have much in common with hypertension and adrenal incidentaloma.Aim...

ea0041ep37 | Adrenal cortex (to include Cushing's) | ECE2016

CYP11B2 polymorphism affects the aldosterone – renin ratio?

Zukowski Lukasz , Mysliwiec Janusz , Wawrusiewicz-Kurylonek Natalia , Gorska Maria

Introduction: Nowadays is believed that primary aldosteronism (PA) is the most frequent cause of secondary hypertension and reaches 10% of whole hypertensive population. The activity of the mineralocorticoid hormone may be change by polymorphism of aldosterone synthase gene (CYP11B2) e.g. in promoter -344T/C region. Aim of this study was to find differences in baseline plasma aldosterone concentration (PAC), plasma renin activity (PRA), aldosterone – renin ratio (ARR) and...

ea0011p780 | Thyroid | ECE2006

Hyperthyreosis treated with thyroid artery embolization

Kaminski GW , Jaroszuk A , Brzozowski K , Kowalczyk A , Zukowski P , Podgajny Z , Twarkowski P , Siekierzynski M

Aim: Evaluation of efficacy and safety of thyroid artery embolization procedure as a method of treatment of hyperthyreosis.Patient and methods: Since May 2004 to July 2005 the thyroid artery embolization procedures have been performed in 9 pts (7 women and 2 men) in mean age 62.3 (44 – 77). The reason for such a treatment were: hyperthyroid goiter with the other organs compression in 5 cases, Graves disease in 2 and thyrotoxicosis type I after amiod...